Published in J Invest Dermatol on September 06, 2007
LYell SYndrome MEsenchymal Stromal Cells Treatment (LYSYME) | NCT04711200
Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis (2010) 3.69
Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol (2011) 1.44
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis (2012) 1.32
Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Med Genet (2011) 1.24
Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc (2010) 1.07
Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients. Korean J Intern Med (2012) 1.06
Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement. Sci Rep (2014) 1.05
Fixed drug eruption resulting from fluconazole use: a case report. J Med Case Rep (2009) 1.02
Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pac Allergy (2013) 1.01
Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms. Asia Pac Allergy (2015) 0.98
Update on the management of antibiotic allergy. Allergy Asthma Immunol Res (2010) 0.95
Large-scale elucidation of drug response pathways in humans. J Comput Biol (2012) 0.93
The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation. Int J Hepatol (2012) 0.91
Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe. Orphanet J Rare Dis (2011) 0.91
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Ther Med (2015) 0.89
Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J (2014) 0.88
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol (2008) 0.88
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study. Eur J Clin Pharmacol (2013) 0.87
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity. Osteoporos Int (2009) 0.85
New advances in the treatment of gout: review of pegloticase. Ther Clin Risk Manag (2010) 0.84
Clinical applications of drug desensitization in the Asia-Pacific region. Asia Pac Allergy (2011) 0.84
An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing. Genet Med (2015) 0.83
Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome. Korean J Ophthalmol (2013) 0.83
Oxcarbazepine induced toxic epidermal necrolysis - a rare case report. Indian J Pharmacol (2015) 0.82
Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. Trials (2015) 0.82
An analysis of drug induced Stevens-Johnson syndrome. Indian J Med Res (2012) 0.81
Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database. J Pharm Health Care Sci (2016) 0.81
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role? Med Sci Monit (2015) 0.81
Lamotrigine-induced toxic epidermal necrolysis confirmed by in vitro granulysin and cytokine assays. Asia Pac Allergy (2014) 0.80
Stevens-johnson syndrome induced by vandetanib. Ann Dermatol (2011) 0.80
Cutaneous side effects of antiosteoporosis treatments. Ther Adv Musculoskelet Dis (2011) 0.80
Update on Quinolone Allergy. Curr Allergy Asthma Rep (2017) 0.79
Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analysis of patients in an integrated allergy repository of a large health care system. J Allergy Clin Immunol Pract (2014) 0.79
Towards scarless wound healing: a comparison of protein expression between human, adult and foetal fibroblasts. Biomed Res Int (2014) 0.79
Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child. Ann Burns Fire Disasters (2014) 0.79
Are Multimorbidities Underestimated in Scoring Systems of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Like in SCORTEN? Eplasty (2012) 0.78
HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs. Yonsei Med J (2016) 0.78
Life-threatening dermatologic adverse events in oncology. Anticancer Drugs (2014) 0.78
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview. Med Sci Monit (2016) 0.78
Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population. Pharmacogenomics J (2016) 0.77
Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study. PLoS One (2013) 0.77
Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome. J Am Med Inform Assoc (2015) 0.77
Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone. Support Care Cancer (2012) 0.76
Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions. Toxins (Basel) (2014) 0.76
Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes. Korean J Intern Med (2015) 0.76
Drug induced exfoliative dermatitis: state of the art. Clin Mol Allergy (2016) 0.76
Antiviral drug allergy. Immunol Allergy Clin North Am (2014) 0.76
Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015. Orphanet J Rare Dis (2017) 0.76
Recurrent Aphthous Stomatitis: A Review. J Clin Aesthet Dermatol (2017) 0.75
Stevens-johnson syndrome induced by carbamazepine treatment in a patient who previously had carbamazepine induced pruritus - a case report -. Korean J Pain (2013) 0.75
Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study. PLoS One (2013) 0.75
Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials. An Bras Dermatol (2017) 0.75
Concurrence of Stevens-Johnson Syndrome and Bilateral Parotitis after Minocycline Therapy. Case Rep Dermatol (2010) 0.75
Issues about diagnosis and treatment of toxic epidermal necrolysis. Indian J Crit Care Med (2012) 0.75
An exploratory factor analysis of the spontaneous reporting of severe cutaneous adverse reactions. Ther Adv Drug Saf (2016) 0.75
The case-crossover design via penalized regression. BMC Med Res Methodol (2016) 0.75
Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. PLoS One (2016) 0.75
A case of toxic epidermal necrolysis (ten) with severe chronic ocular complications in a healthy 46-year-old woman. Ann Burns Fire Disasters (2010) 0.75
A case report on toxic epidermal necrolysis with etoricoxib. Indian J Pharmacol (2015) 0.75
Lyell's Syndrome and Antimalarials: A Case Report and Clinical Review. J Glob Infect Dis (2017) 0.75
Who should support the costs of severe adverse drug reactions? Ther Adv Drug Saf (2011) 0.75
Clinical features of immediate hypersensitivity to isopropylantipyrine. Allergy Asthma Immunol Res (2012) 0.75
Databases for Clinical Research. J Invest Dermatol (2015) 0.75
Phenytoin-induced toxic epidermal necrolysis: Review and recommendations. J Pharmacol Pharmacother (2016) 0.75
Cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteine. Case Reports Immunol (2012) 0.75
Successful use of allopurinol in a patient on dialysis. BMJ Case Rep (2012) 0.75
Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital. J Clin Diagn Res (2015) 0.75
Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation. Int J Mol Sci (2016) 0.75
Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge. Indian J Pharmacol (2016) 0.75
Stevens Johnson syndrome after carbamazepine and SJS/TEN overlap syndrome after amoxicillin: case reports and a review. Arch Med Sci (2010) 0.75
HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. Neurology (2017) 0.75
Toxic epidermal necrolysis in hemodialysis patient. Adv Biomed Res (2015) 0.75
Acute compartment syndrome of the forearm as a rare complication of toxic epidermal necrolysis: a case report. J Med Case Rep (2012) 0.75
HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese. Pharmacogenomics J (2015) 0.75
Toxic epidermal necrolysis: a retrospective analysis of 17 cases from central Tunisia. Pan Afr Med J (2014) 0.75
[Not Available]. Can Pharm J (Ott) (2013) 0.75
Inadvertent Provocative Oral Ondansetron use Leading to Toxic Epidermal Necrolysis in an HIV-infected Patient. Indian J Dermatol (2012) 0.75
Co-amoxiclav-induced Stevens Johnson syndrome in a child. Pan Afr Med J (2013) 0.75
A pilot study on the incidence of severe photosensitivity reactions leading to hospitalization linked to topical ketoprofen and other medications in selected European regions. Pharmacol Res Perspect (2016) 0.75
Review of Toxic Epidermal Necrolysis. Int J Mol Sci (2016) 0.75
Characterization of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study. Drugs Real World Outcomes (2017) 0.75
Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature. Clin Mol Allergy (2017) 0.75
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions. Taiwan J Ophthalmol (2016) 0.75
Toxic epidermal necrolysis in a child with lupus-associated pancreatitis. Rheumatol Int (2017) 0.75
Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia. Br J Dermatol (2017) 0.75
[Severe cutaneous drug reactions in children]. Hautarzt (2017) 0.75
Stevens-Johnson syndrome/toxic epidermal necrolysis caused by cefadroxil in a cat. JFMS Open Rep (2016) 0.75
Flow cytometry test to screen for HLA-B*58:01-associated allopurinol hypersensitivity. Clin Rheumatol (2014) 0.75
Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS-TEN overlap and potential drug-drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital. Ther Clin Risk Manag (2017) 0.75
Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions - a review of spontaneous reports. Ther Clin Risk Manag (2017) 0.75
Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study. Eur J Clin Pharmacol (2015) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med (2004) 12.73
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med (2006) 10.48
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
Randomized controlled trial testing the impact of high-protection sunscreens on sun-exposure behavior. Arch Dermatol (2005) 9.42
Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med (2005) 8.46
Estimating the impact of school closure on influenza transmission from Sentinel data. Nature (2008) 7.98
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol (2008) 7.35
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 5.91
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med (2002) 5.58
The signature features of influenza pandemics--implications for policy. N Engl J Med (2009) 5.37
Risk factors of influenza transmission in households. Br J Gen Pract (2004) 5.25
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data. Am J Epidemiol (2005) 3.58
More diseases tracked by using Google Trends. Emerg Infect Dis (2009) 3.53
Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis (2006) 3.43
Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct (2006) 3.18
Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog (2010) 3.15
Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology (2003) 2.93
Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales. PLoS Comput Biol (2013) 2.85
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol (2007) 2.71
Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology (2012) 2.68
Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis (2008) 2.61
Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog (2007) 2.52
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol (2009) 2.50
Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol (2002) 2.49
Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol (2006) 2.49
The early diversification of influenza A/H1N1pdm. PLoS Curr (2009) 2.44
A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med (2007) 2.41
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med (2013) 2.38
Acute generalized exanthematous pustulosis following a spider bite: report of 3 cases. J Am Acad Dermatol (2006) 2.38
Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerg Infect Dis (2004) 2.37
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol (2004) 2.33
An elaborated feeding cycle model for reductions in vectorial capacity of night-biting mosquitoes by insecticide-treated nets. Malar J (2007) 2.33
Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. J Clin Oncol (2013) 2.29
In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am J Hum Genet (2003) 2.21
Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog (2008) 2.09
Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol (2003) 1.94
The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission. Malar J (2005) 1.93
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics (2008) 1.92
Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis (2009) 1.91
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res (2010) 1.89
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis (2010) 1.85
Prediction of the spread of influenza epidemics by the method of analogues. Am J Epidemiol (2003) 1.85
Vaccinating to protect a vulnerable subpopulation. PLoS Med (2007) 1.76
Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis (2008) 1.69
Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ (2012) 1.69
Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer (2007) 1.68
Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol (2009) 1.66
Association of influenza epidemics with global climate variability. Eur J Epidemiol (2004) 1.64
Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allergy Clin Immunol (2006) 1.63
Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology (2002) 1.62
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. J Hepatol (2011) 1.60
Alcohol-attributable mortality in France. Eur J Public Health (2013) 1.57
Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics (2009) 1.53
Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol (2003) 1.53
Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol (2006) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis (2013) 1.49
Virus diversity in a winter epidemic of acute diarrhea in France. J Clin Microbiol (2002) 1.48
A method to assess seasonality of urinary tract infections based on medication sales and google trends. PLoS One (2013) 1.46
Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol (2002) 1.44
Medication sales and syndromic surveillance, France. Emerg Infect Dis (2006) 1.42
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Could measuring of perceived risk among general practitioners have helped anticipate the French BSE crisis? Eur J Epidemiol (2004) 1.40
Prediction of clinical response to excimer laser treatment in vitiligo by using neural network models. Dermatology (2009) 1.40
Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf (2007) 1.38
Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir Viruses (2009) 1.35
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J (2002) 1.35
Online detection and quantification of epidemics. BMC Med Inform Decis Mak (2007) 1.33
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis (2012) 1.32
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol (2002) 1.32
Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res (2010) 1.30
Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One (2009) 1.29
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol (2013) 1.28
A simple method for molecular detection of Swine-origin and human-origin influenza a virus. Vector Borne Zoonotic Dis (2010) 1.27
An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat (2005) 1.27
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol (2009) 1.26
Seroprevalence of trichodysplasia spinulosa-associated polyomavirus. Emerg Infect Dis (2011) 1.25